Top Markets
#1 DogBull DogBull +54.40%
#2 Siren Siren +31.81%
#3 OriginTrail OriginTrail +15.19%
#4 Verus Coin Verus Coin +11.30%
#5 Tutorial Tutorial +8.83%
#6 Yield Basis Yield Basis +8.48%
#7 Prom Prom +8.33%
#8 Falcon Finance Falcon Finance +7.80%
#9 COTI COTI +7.42%
#10 Stargate Finance Stargate Finance +6.97%
Coin of the day
DogBull DogBull
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRV
Classement en actions #22054
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Prix de l'action
$2.23
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$95.23M
Changement (1 jour)
1.14%
Changement (1 an)
63.60%
Pays
US
Échange Acrivon Therapeutics, Inc. Common Stock (ACRV)

Catégorie

Healthcare
Historique du prix de l'action pour Acrivon Therapeutics, Inc. Common Stock (ACRV)
Prix de clôture le plus élevé : $1.94 le 2026-08-01

Prix de clôture le plus bas : $13.89 le 2022-11-01
Historique du prix de l'action de Acrivon Therapeutics, Inc. Common Stock de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -23.66%
2025 -63.95%
2024 34.00%
2023 -58.79%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH